Inflammatory Bowel Disease

Chronic immune-mediated inflammation of the GI tract, comprising Crohn's disease and ulcerative colitis.

Thuốc cho tình trạng này

Adalimumab

CHEMBL1201580 · Antibody

Phase 4

Balsalazide

CHEMBL1201346 · Small molecule

Phase 4

Balsalazide Disodium

CHEMBL1200760 · Small molecule

Phase 4

Budesonide

CHEMBL1370 · Small molecule

Phase 4

Certolizumab Pegol

CHEMBL1201831 · Antibody

Phase 4

Cyclosporine

CHEMBL160 · Protein

Phase 4

Darvadstrocel

CHEMBL4298180 · Cell

Phase 4

Etrasimod

CHEMBL3358920 · Small molecule

Phase 4

Ferric Derisomaltose

CHEMBL4298187 · Oligosaccharide

Phase 4

Ferric Maltol

CHEMBL4298110 · Small molecule

Phase 4

Filgotinib

CHEMBL3301607 · Small molecule

Phase 4

Filgotinib Maleate

CHEMBL4298167 · Small molecule

Phase 4

Golimumab

CHEMBL1201833 · Antibody

Phase 4

Infliximab

CHEMBL1201581 · Antibody

Phase 4

Loperamide

CHEMBL841 · Small molecule

Phase 4

Mesalamine

CHEMBL704 · Small molecule

Phase 4

Methotrexate

CHEMBL34259 · Small molecule

Phase 4

Mirikizumab

CHEMBL3990014 · Antibody

Phase 4

Natalizumab

CHEMBL1201607 · Antibody

Phase 4

Olsalazine

CHEMBL425 · Small molecule

Phase 4

Olsalazine Sodium

CHEMBL1201013 · Small molecule

Phase 4

Prednisolone

CHEMBL131 · Small molecule

Phase 4

Prednisolone Acetate

CHEMBL1152 · Small molecule

Phase 4

Prednisolone Phosphoric Acid

CHEMBL1201231 · Small molecule

Phase 4

Prednisolone Sodium Phosphate

CHEMBL1201014 · Small molecule

Phase 4

Prednisolone Tebutate

CHEMBL1200909 · Small molecule

Phase 4

Risankizumab

CHEMBL3990029 · Antibody

Phase 4

Sodium Picosulfate

CHEMBL1697768 · Small molecule

Phase 4

Sulfasalazine

CHEMBL421 · Small molecule

Phase 4

Tofacitinib

CHEMBL221959 · Small molecule

Phase 4

Tofacitinib Citrate

CHEMBL2103743 · Small molecule

Phase 4

Upadacitinib

CHEMBL3622821 · Small molecule

Phase 4

Upadacitinib Hemihydrate

CHEMBL5315119 · Small molecule

Phase 4

Ustekinumab

CHEMBL1201835 · Antibody

Phase 4

Vedolizumab

CHEMBL1743087 · Antibody

Phase 4

Related Conditions